Evidence map›Paper›PMID 23914338›Full record

ArticleBioResearch open access2013

One-step surgical procedure for the treatment of osteochondral defects with adipose-derived stem cells in a caprine knee defect: a pilot study.

Wouter J F M Jurgens, Robert Jan Kroeze, Behrouz Zandieh-Doulabi, Annemieke van Dijk, Greetje A P Renders, Theo H Smit, Florine J van Milligen, Marco J P F Ritt, Marco N Helder

Registry-linked trialAbstract read
In one paragraph

Article in BioResearch open access, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07121556 (Randomized Double- Blind Study on the Treatment of Symptomatic Bilateral Knee Osteoarthritis), which is not on this map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07121556 narecruitingnot on this mapstarted 2025, after this paper: background citation

Randomized Double- Blind Study on the Treatment of Symptomatic Bilateral Knee Osteoarthritis: Intra-articular Injection of Autologous Microfragmented Adipose Tissue and Hyaluronic Acid vs Intra Articular Injection of Autologous Microfragmented Adipose Tissue. Double-Blind Randomized Controlled Clinical Trial

TypeinterventionalSponsorIstituto Ortopedico RizzoliRan2025 to 2030Enrolled100ConditionsOsteoarthritis Knees BothArmsMFAT + HA left knee - MFAT + placebo right knee, MFAT + HA right knee - MFAT + placebo left knee
3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Efficacy of fractional COStem cell research & therapy · 2023
    Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Treatment of medication-related osteonecrosis of the jaw with cell therapy.Frontiers in cell and developmental biology · 2024
    Article
  8. The Use of Stromal Vascular Fraction in Long Bone Defect Healing in Sheep.Animals : an open access journal from MDPI · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Orthobiologics in the treatment of hip disorders.World journal of stem cells · 2021
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wouter J F M JurgensDepartment of Plastic, Reconstructive, & Hand Surgery, VU University Medical Center (VUmc), Amsterdam, The Netherlands . ; MOVE/Skeletal Tissue Engineering Group Amsterdam (STEGA) , Amsterdam, The Netherlands .
Robert Jan Kroeze
Behrouz Zandieh-Doulabi
Annemieke van Dijk
Greetje A P Renders
Theo H Smit
Florine J van Milligen
Marco J P F Ritt
Marco N Helder

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regenerative therapies offer attractive alternatives for the treatment of osteochondral defects. Adipose-derived stromal vascular fraction (SVF) cells allow the development of one-step surgical procedures by their abundant availability and high frequency. In this pilot study we evaluated the in vivo safety, feasibility, and efficacy of this concept using scaffolds seeded with freshly isolated (SVF) or cultured adipose stem cells (ASCs), and compared these to their acellular counterparts. Osteochondral defects were created in medial condyles and trochlear grooves in knees of eight goats. Defects were filled with acellular collagen I/III scaffolds or scaffolds seeded with SVF cells or cultured ASCs. Osteochondral regeneration was evaluated after 1 and 4 months by macroscopy, immunohistochemistry, biomechanical analysis, microCT analysis, and biochemistry. After 1 month, no adverse effects were noted. Microscopic, but not macroscopic evaluation showed considerable yet not significant differences, with cell-loaded constructs showing more extensive regeneration. After 4 months, acellular constructs displayed increased regeneration, however, to a lesser degree than cell-treated constructs. The latter exhibited more extensive collagen type II, hyaline-like cartilage, and higher elastic moduli, and their glycosaminoglycan content in the cartilaginous layer better approached native tissue values. Moreover, their defect regions contained higher levels of regenerated, mature subchondral bone with more intense collagen type I staining. SVF cells tended to perform best on all parameters. In summary, this pilot study demonstrated the preclinical safety and feasibility of a one-step surgical procedure for osteochondral defect regeneration. Similar regeneration was found between freshly isolated SVF cells and cultured ASCs. Larger studies with longer follow-up are required to substantiate these findings.

Indexed as

adipose tissuecaprinecartilage repairin vivomesenchymal stem cellsosteochondral

Identifiers

PMID23914338
PMCPMC3731690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.